O Shaughnessy Asset Management LLC Acquires Shares of 1,132 Smith & Nephew plc (SNN)

Share on StockTwits

O Shaughnessy Asset Management LLC acquired a new position in shares of Smith & Nephew plc (NYSE:SNN) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,132 shares of the medical equipment provider’s stock, valued at approximately $42,000.

Other large investors have also added to or reduced their stakes in the company. Comerica Bank increased its position in shares of Smith & Nephew by 15.3% during the 3rd quarter. Comerica Bank now owns 33,674 shares of the medical equipment provider’s stock worth $1,134,000 after purchasing an additional 4,472 shares in the last quarter. MML Investors Services LLC increased its position in Smith & Nephew by 59.2% in the 3rd quarter. MML Investors Services LLC now owns 13,842 shares of the medical equipment provider’s stock valued at $513,000 after acquiring an additional 5,148 shares in the last quarter. Eagle Asset Management Inc. increased its position in Smith & Nephew by 9.2% in the 3rd quarter. Eagle Asset Management Inc. now owns 17,833 shares of the medical equipment provider’s stock valued at $661,000 after acquiring an additional 1,508 shares in the last quarter. Crossmark Global Holdings Inc. increased its position in Smith & Nephew by 4.7% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 374,014 shares of the medical equipment provider’s stock valued at $13,872,000 after acquiring an additional 16,923 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in Smith & Nephew by 18.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 76,184 shares of the medical equipment provider’s stock valued at $2,827,000 after acquiring an additional 11,873 shares in the last quarter. 9.32% of the stock is owned by institutional investors.

Several equities research analysts have weighed in on SNN shares. JPMorgan Chase & Co. cut shares of Smith & Nephew from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 1st. BNP Paribas cut shares of Smith & Nephew from an “outperform” rating to a “neutral” rating in a research report on Friday, February 8th. Zacks Investment Research raised Smith & Nephew from a “hold” rating to a “buy” rating and set a $42.00 target price for the company in a research note on Wednesday, December 5th. Finally, Morgan Stanley raised Smith & Nephew from an “equal weight” rating to an “overweight” rating in a research note on Monday, December 10th. Five analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $43.50.

Smith & Nephew stock opened at $39.39 on Friday. Smith & Nephew plc has a 1 year low of $32.22 and a 1 year high of $40.78. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.10 and a quick ratio of 1.15. The company has a market capitalization of $17.09 billion, a PE ratio of 19.50, a PEG ratio of 2.97 and a beta of 0.43.

The company also recently announced a semiannual dividend, which will be paid on Wednesday, May 8th. Shareholders of record on Friday, April 5th will be given a dividend of $0.44 per share. This represents a yield of 2.31%. The ex-dividend date of this dividend is Thursday, April 4th. This is an increase from Smith & Nephew’s previous semiannual dividend of $0.25. Smith & Nephew’s dividend payout ratio is currently 26.73%.

WARNING: This piece of content was reported by Zolmax and is the property of of Zolmax. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://zolmax.com/investing/o-shaughnessy-asset-management-llc-acquires-shares-of-1132-smith-nephew-plc-snn/2965299.html.

Smith & Nephew Profile

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Further Reading: Return on Investment (ROI)

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dinero Price Tops $0.0022
Dinero Price Tops $0.0022
Critical Survey: Evofem Biosciences  versus Its Peers
Critical Survey: Evofem Biosciences versus Its Peers
Ocular Therapeutix  Stock Price Down 5.3%
Ocular Therapeutix Stock Price Down 5.3%
SPDR S&P Oil & Gas Equipment & Services ETF  Stock Price Down 5.4%
SPDR S&P Oil & Gas Equipment & Services ETF Stock Price Down 5.4%
ThingsOperatingSystem Hits 24-Hour Volume of $241,743.00
ThingsOperatingSystem Hits 24-Hour Volume of $241,743.00
EBCoin Price Reaches $0.0009 on Exchanges
EBCoin Price Reaches $0.0009 on Exchanges


 
© 2006-2019 Zolmax.